Darren Marc Long, Vice President at COGNEX CORP (NASDAQ:CGNX), recently disclosed transactions involving the company's common stock. The filings show that on May 27, 2026, Mr. Long executed sales of shares totaling an estimated $1.34 million. Concurrently, his reported activity included acquiring shares valued at approximately $970,717 through the exercise of previously granted options.
The specifics of the disposition reveal that Mr. Long sold a total of 20,252 shares of Cognex common stock. These sales were executed across a price range spanning from $66.3215 to $66.5201 per share. The timing of these reported transactions is notable given the recent performance trajectory of Cognex shares. Over the past year, the stock has achieved an 119% return, and its gains year-to-date stand at 84%. Currently, the stock trades at $66.02, supporting a market capitalization of $10.96 billion.
In contrast to the sales, Mr. Long also acquired 18,673 shares of Cognex common stock by utilizing previously granted stock options. The acquisition prices for these shares varied between $49.12 and $56.44 per share. These vested options were structured over several years and included grants from multiple dates: those originally issued on February 20, 2018, which vested in five equal annual installments; options granted on February 19, 2019, also vesting across five equal annual installments; and a third set of options given on May 9, 2022, which were structured to vest in three equal annual installments.
Following the entirety of these reported transactions, Mr. Long's direct ownership stake in Cognex common stock was calculated at 3,990 shares. The transaction report also provided details regarding other derivative holdings he maintains, including various grants of non-qualified stock options and restricted stock units, with future exercise dates specified.
These insider transactions are set against a backdrop of significant corporate developments for Cognex. In recent news, the corporation released impressive financial results for the first quarter of 2026. These figures surpassed expectations from Wall Street analysts. Specifically, the company reported an adjusted earnings per share of $0.34, which exceeded the forecasted amount of $0.25. Furthermore, revenue reached $268 million, surpassing the expected benchmark of $245.45 million.
The positive financial outcomes led several investment firms to reassess their outlook on Cognex. JPMorgan upgraded its stock rating to Overweight from Neutral. The firm cited growth within AI-enabled vision systems and an increase in market diversification as key drivers, subsequently raising its price target to $75. Similarly, Bernstein SocGen Group maintained an Outperform rating while setting its price target at $75. DA Davidson also increased its price target, adjusting it to $62 from a previous $55, although it kept the overall rating at Neutral, following adjustments made to both sales and earnings projections for 2026 and 2027.
Additionally, Cognex announced the introduction of OneVision. This platform is designed as an AI vision development tool specifically for manufacturing inspection. The utility of this new platform has been demonstrated through testing with over 100 customers.
Key Points and Market Implications
The reported activity highlights several key dynamics within the company's structure and market position:
-
Risks
- The current valuation assessment by InvestingPro suggests the stock may appear overvalued based on its Fair Value analysis.
- Mr. Long's substantial selling activity (20,252 shares) could signal profit-taking or a reduction in immediate confidence despite positive results.
More from Insider Trading